arrow_back Back to App

Strengthening Border Control: Combating Illicit Fentanyl

This act aims to enhance U.S. border security by improving the detection and interdiction of illicit fentanyl and its precursors. Citizens can expect increased government efforts in combating drug trafficking, potentially leading to improved public safety and health. New technologies and strategies are intended to make anti-smuggling efforts more effective.
Key points
Research into new technologies for detecting fentanyl and its precursors, including in counterfeit pills.
Evaluation of current technologies and strategies used for illicit drug interdiction at borders to improve their effectiveness.
Requirement for regular reports and analyses on the effectiveness of border anti-drug efforts, including cost-benefit assessments.
Supplementing drug control strategies with new performance measures for border regions, such as the Southwest, Northern, and Caribbean borders.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_8316
Sponsor: Rep. Spanberger, Abigail Davis [D-VA-7]
Process start date: 2022-07-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Securing America’s Borders Against Fentanyl Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8316.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-07-07.

What are the main provisions?

Key points include:

  • Research into new technologies for detecting fentanyl and its precursors, including in counterfeit pills.
  • Evaluation of current technologies and strategies used for illicit drug interdiction at borders to improve their effectiveness.
  • Requirement for regular reports and analyses on the effectiveness of border anti-drug efforts, including cost-benefit assessments.
  • Supplementing drug control strategies with new performance measures for border regions, such as the Southwest, Northern, and Caribbean borders.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Spanberger, Abigail Davis [D-VA-7].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Immigration and Citizenship.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Security Health